Boston Scientific Executive Compensation
Boston Scientific Corporation is an American manufacturer of medical devices used in various interventional medical specialties.
Named Executive Officers — FY2025
Compensation Analysis
Computed directly from SEC-sourced figures tracked on this page — not a general description.
Boston Scientific discloses FY2025 compensation for 7 named executive officers, totaling $35.8M. Michael Mahoney, the Chairman & CEO, accounts for 42% of that combined total.
Michael Mahoney's total compensation rose 302% year-over-year, from $3.7M in FY2024 to $15.1M in FY2025.
Cash compensation (salary plus bonus) made up 16% of Boston Scientific's FY2025 tracked executive pay, with stock awards accounting for 84%. That's notably more stock-weighted than the typical Healthcare company in this dataset, where stock awards average 0% of tracked pay.
Among 78 other Healthcare companies in this dataset, Boston Scientific's combined tracked executive pay of $35.8M ranks in the 85th percentile (industry median: $12.5M). Its highest-paid executive, Michael Mahoney, ranks in the 73th percentile for top-executive pay in the sector (industry median: $6.0M).
Compensation figures on this page for Boston Scientific come directly from its SEC DEF 14A proxy statement(s), filed with the SEC via EDGAR — not from crowdsourced or self-reported salary data.